Pharma & biotech
The journey doesn't stop at the last infusion, nor after the rehabilitation pathway. We offer lifestyle support with exportable real-world evidence for market-access and reimbursement dossiers.
RevOnc offers hospitals, pharma companies, insurers and occupational health services a ready-to-use digital aftercare platform. Grounded in a pilot study, no IT integration needed.
We'll get in touch with you.
The journey doesn't stop at the last infusion, nor after the rehabilitation pathway. We offer lifestyle support with exportable real-world evidence for market-access and reimbursement dossiers.
Your patients disappear from view after discharge. RevOnc is the digital extension of your care pathway. Personalised exercise without extra burden on your team.
Shorten absence duration, offer oncological aftercare and differentiate from competitors. Measurable impact on return to work.
Your buddy for quality of life after cancer
RevOnc supports patients where traditional care often stops: between treatment and daily life.
| Functionality | Standalone aftercare tools | RevOnc |
|---|---|---|
| Mental support | ~ | ✓ |
| Lifestyle guidance | ~ | ✓ |
| AI-driven coaching | ~ | ✓ |
| Developed with patients | ~ | ✓ |
| Clinically grounded | ~ | ✓ |
| Supports recovery at home | ~ | ✓ |
Based on the science of exercise oncology and developed together with healthcare professionals.
RevOnc combines physical activity, mental support and lifestyle guidance in one platform.
Developed based on insights from more than 100 patients and healthcare professionals.
No. RevOnc works as a standalone solution. Patients download the app themselves without your IT department having to configure anything. EMR integration is optional and can be added later.
RevOnc works with a B2B licensing model. The exact price depends on the collaboration type and volume. Contact us for a tailored quote.
Yes. RevOnc was tested in a pilot study at AZorg Aalst with 43 patients over 10 weeks, in collaboration with Prof. Marieke De Craemer from Ghent University.
Yes. Depending on the collaboration model, the app can be adapted to your visual identity. This is available for hospitals, pharma companies and insurers.
Yes. Data is processed under GDPR and hosted on European infrastructure. Organisations only receive aggregated, non-identifiable insights.
Because no IT integration is required, a pilot can usually be launched within a few weeks. The concrete planning depends on the collaboration model.
Patients included
Programme AZorg Aalst
Patient satisfaction
Want to continue after the programme
We'll send you the full results of our pilot study.
We'll send the report to your email within 24 hours.